CBPO [China Biologic Products] SC 13D/A: (Original Filing)

[2 SCHEDULE 13D G21515104 CUSIP No. 1. Names of Reporting Persons. Parfield International Ltd. 2. Check the Appropriate Box if a Member of a Group (See Instructions). (a) ☒ (b) ◻ 3. SEC Use Only 4. Source of Funds (See Instructions) WC 5. ☐ 6. Citizenship or Place of Organization British Virgin Islan]

CBPO [China Biologic Products] SC 13D/A: 2 SCHEDULE 13D G21515104 CUSIP No. 1. Names

[2 SCHEDULE 13D G21515104 CUSIP No. 1. Names of Reporting Persons. Parfield International Ltd. 2. Check the Appropriate Box if a Member of a Group (See Instructions). (a) ☒ (b) ◻ 3. SEC Use Only 4. Source of Funds (See Instructions) WC 5. ☐ 6. Citizenship or Place of Organization British Virgin Islan]

GURE [GULF RESOURCES] 10-K: (Original Filing)

[] [General As of April 14, 2020, our authorized capital stock consists of 80,000,000 shares of common stock, par value $0.0005 per share, of which 9,517,427 shares are issued and outstanding, and 1,000,000 shares of preferred stock, par value $0.001 per share, of which none are outstanding. Common S]

By | 2020-10-01T02:07:53+00:00 April 14th, 2020|Categories: Chinese Stocks, GURE, SEC Original|Tags: , , , , , |0 Comments

GURE [GULF RESOURCES] 10-K:

[] [General As of April 14, 2020, our authorized capital stock consists of 80,000,000 shares of common stock, par value $0.0005 per share, of which 9,517,427 shares are issued and outstanding, and 1,000,000 shares of preferred stock, par value $0.001 per share, of which none are outstanding. Common S]

By | 2020-10-01T02:07:56+00:00 April 14th, 2020|Categories: Chinese Stocks, GURE, Webplus ver|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Announces Approval of Human Clinical Trial for a Vaccine Candidate Against COVID-19 BEIJING--(BUSINESS WIRE)-- April 14, 2020-- Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the Company has obta]

By | 2020-10-01T15:40:08+00:00 April 14th, 2020|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: Sinovac Announces Approval of Human Clinical Trial for

[Sinovac Announces Approval of Human Clinical Trial for a Vaccine Candidate Against COVID-19 BEIJING--(BUSINESS WIRE)-- April 14, 2020-- Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the Company has obta]

By | 2020-10-01T15:40:12+00:00 April 14th, 2020|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments

CYOU [Changyou.com] 6-K: (Original Filing)

[Changyou.com Announces Filing of Definitive Plan of Merger for Going-Private Transaction fully-vested Because Changyou Merger Co. owns over 90% of the voting power represented by all issued and outstanding shares of Changyou, the Changyou Merger will be in the form of a short-form merger of Changyou]

By | 2020-10-01T08:13:31+00:00 April 14th, 2020|Categories: Chinese Stocks, CYOU, SEC Original|Tags: , , , , , |0 Comments
Skip to toolbar